Cargando…
自噬在EGFR-TKI类肿瘤靶向药物对肺癌的治疗和耐药中作用的研究进展
Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is a group of targeted-drugs which effectively inhibits the growth of tumor cells with sensitive mutations in EGFR. However, the innate and acquired resistance are major obstacles of the efficiency. Autophagy is a highly conserved...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972950/ https://www.ncbi.nlm.nih.gov/pubmed/27666552 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.09.09 |